See more : Sharingtechnology, Inc. (3989.T) Income Statement Analysis – Financial Results
Complete financial analysis of FERMENTALG (ALGAE.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of FERMENTALG, a leading company in the Biotechnology industry within the Healthcare sector.
- Kotra Industries Berhad (0002.KL) Income Statement Analysis – Financial Results
- Japan Best Rescue System Co.,Ltd. (2453.T) Income Statement Analysis – Financial Results
- Huntsman Exploration Inc. (HMAN.V) Income Statement Analysis – Financial Results
- Global Surfaces Limited (GSLSU.BO) Income Statement Analysis – Financial Results
- AME Elite Consortium Berhad (5293.KL) Income Statement Analysis – Financial Results
Fermentalg (ALGAE.PA)
About Fermentalg
Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.06M | 7.65M | 5.65M | 2.21M | 0.00 |
| Cost of Revenue | 3.52M | 5.83M | 3.66M | 1.11M | 0.00 |
| Gross Profit | 535.00K | 1.82M | 1.98M | 1.09M | 0.00 |
| Gross Profit Ratio | 13.19% | 23.76% | 35.12% | 49.48% | 0.00% |
| Research & Development | 4.41M | 3.91M | 3.62M | 4.42M | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 3.25M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 167.00K | 0.00 | 0.00 | 0.00 | 3.25M |
| Other Expenses | 7.76M | 0.00 | 0.00 | 0.00 | -5.06M |
| Operating Expenses | 12.34M | 10.68M | 10.46M | 9.99M | -1.81M |
| Cost & Expenses | 15.87M | 16.52M | 14.13M | 11.10M | -1.81M |
| Interest Income | 294.00K | 17.00K | 51.00K | 56.00K | 47.00K |
| Interest Expense | 482.00K | 441.00K | 691.00K | 728.00K | 494.00K |
| Depreciation & Amortization | 3.16M | 2.55M | 723.00K | 1.32M | 0.00 |
| EBITDA | -10.51M | -6.89M | -8.06M | -4.83M | -6.33M |
| EBITDA Ratio | -259.06% | -87.89% | -142.73% | -342.49% | 0.00% |
| Operating Income | -11.81M | -9.27M | -8.78M | -8.87M | -13.61M |
| Operating Income Ratio | -291.05% | -121.21% | -155.53% | -402.18% | 0.00% |
| Total Other Income/Expenses | -2.34M | -844.00K | -994.00K | -698.00K | -447.00K |
| Income Before Tax | -14.15M | -9.87M | -6.85M | -6.88M | 0.00 |
| Income Before Tax Ratio | -348.71% | -129.11% | -121.30% | -311.88% | 0.00% |
| Income Tax Expense | 1.00K | 0.00 | 0.00 | 1.00K | 0.00 |
| Net Income | -14.15M | -9.87M | -6.85M | -6.88M | 0.00 |
| Net Income Ratio | -348.73% | -129.11% | -121.30% | -311.93% | 0.00% |
| EPS | -0.32 | -0.24 | -0.19 | -0.32 | 0.00 |
| EPS Diluted | -0.32 | -0.24 | -0.19 | -0.32 | 0.00 |
| Weighted Avg Shares Out | 44.21M | 41.41M | 35.77M | 21.66M | 21.66M |
| Weighted Avg Shares Out (Dil) | 44.24M | 41.41M | 35.77M | 21.66M | 21.66M |
Source: https://incomestatements.info
Category: Stock Reports